Interferon Alfa-N3

CHEMBL2109047 Phase 4 Đã phê duyệt Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

This naturally derived human interferon alfa is used as an intralesional injection to treat refractory genital warts (condyloma acuminata). It works by stimulating local immune responses to clear the human papillomavirus (HPV)-infected cells. It is used when other treatments have failed.

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This naturally derived human interferon alfa is used as an intralesional injection to treat refractory genital warts (condyloma acuminata). It works by stimulating local immune responses to clear the human papillomavirus (HPV)-infected cells. It is used when other treatments have failed.

Yes, Interferon Alfa-N3 is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2109047. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.